These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 21353101)

  • 41. Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review.
    Elia AE; Filippini G; Calandrella D; Albanese A
    Mov Disord; 2009 Apr; 24(6):801-12. PubMed ID: 19224614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis.
    Andringa A; van de Port I; van Wegen E; Ket J; Meskers C; Kwakkel G
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1703-1725. PubMed ID: 30796921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
    Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
    J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    Adv Ther; 2019 Jan; 36(1):187-199. PubMed ID: 30484117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does botulinum toxin treatment improve upper limb active function?
    Levy J; Molteni F; Cannaviello G; Lansaman T; Roche N; Bensmail D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):234-240. PubMed ID: 29960017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of botulinum toxin injections in the upper limbs of children with cerebral palsy: A systematic review of the literature.
    Klein C; Gouron R; Barbier V
    Orthop Traumatol Surg Res; 2024 May; 110(3):103578. PubMed ID: 36754169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
    Santamato A; Panza F; Filoni S; Ranieri M; Solfrizzi V; Frisardi V; Dellomonaco A; Amoruso MT; Amoruso L; Kehoe PG; Megna M; Fiore P
    Brain Inj; 2010; 24(9):1108-12. PubMed ID: 20569045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Sun LC; Chen R; Fu C; Chen Y; Wu Q; Chen R; Lin X; Luo S
    Biomed Res Int; 2019; 2019():8329306. PubMed ID: 31080830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
    J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke.
    Gordon MF; Brashear A; Elovic E; Kassicieh D; Marciniak C; Liu J; Turkel C;
    Neurology; 2004 Nov; 63(10):1971-3. PubMed ID: 15557529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.
    Chou R; Peterson K; Helfand M
    J Pain Symptom Manage; 2004 Aug; 28(2):140-75. PubMed ID: 15276195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of spasticity with botulinum toxin.
    O'Brien CF
    Clin J Pain; 2002; 18(6 Suppl):S182-90. PubMed ID: 12569967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IncobotulinumtoxinA Treatment in Upper-Limb Poststroke Spasticity in the Open-Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    PM R; 2020 May; 12(5):491-499. PubMed ID: 31647185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.
    Shaw LC; Price CI; van Wijck FM; Shackley P; Steen N; Barnes MP; Ford GA; Graham LA; Rodgers H;
    Stroke; 2011 May; 42(5):1371-9. PubMed ID: 21415398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity.
    Kaku M; Simpson DM
    Drug Des Devel Ther; 2016; 10():1085-99. PubMed ID: 27022247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.